Large-Bore Vessel Closure Devices - Strategic Insights: Analysis 2025 and Forecasts 2033

Large-Bore Vessel Closure Devices by Type (8F, 9F-15F, 16F-21F, above 21F), by Application (Angiography Surgery, Interventional Procedures), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $652.6 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $652.6 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Large-Bore Vessel Closure Devices Market Size | CAGR 8.8 Forecast 2033

Large-Bore Vessel Closure Devices - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $652.6 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $652.6 million

CAGR: 8.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Large-Bore Vessel Closure Devices Market Overview

Large‑bore vessel closure devices are specialized medical products designed to achieve rapid hemostasis after percutaneous procedures that require arterial access diameters of 8 mm or greater, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair. Their clinical relevance lies in minimizing bleeding complications, shortening hospital stays, and supporting the shift toward minimally invasive interventions. The Large‑Bore Vessel Closure Devices market size was estimated at approximately $1.2 billion in 2025, and the growth outlook projects a CAGR of 7% through the 2026‑2033 market forecast, reflecting robust industry expansion driven by rising procedural volumes and aging demographics.

Loading chart…

Three forces dominate the market dynamics: (1) technological innovation, with plug‑based systems gaining traction for their ease of deployment; (2) regulatory momentum, as the FDA and EMA streamline approvals for next‑generation devices; and (3) competitive intensity, where incumbents such as Abbott, Terumo, and Philips intensify R&D spend to capture market share. North America remains the largest region, underpinned by early adoption and favorable reimbursement, while Asia‑Pacific emerges as the fastest‑growing market, propelled by expanding cardiovascular procedure volumes and rising healthcare investment.

Report Overview

Report Attribute	Details
Market size value in 2025	652.60 million
Revenue forecast in 2033	1.28 billion
Growth rate	CAGR of 8.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Terumo Corporation; Cordis; Teleflex Incorporated; Morrris Innovative
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Large-Bore Vessel Closure Devices market is shaped by a set of interlocking forces that influence its trajectory through 2029, affecting both market size and the growth forecast.

Growth Drivers2 items

Expansion of transcatheter structural heart interventions, especially TAVR and MitraClip, drives demand for rapid hemostasis solutions, propelling the Large-Bore Vessel Closure Devices market growth forecast to a double‑digit CAGR through 2029.

Reimbursement reforms in US Medicare and European health systems that now bundle procedural costs with closure‑device fees reduce out‑of‑pocket barriers, directly enlarging the Large‑Bore Vessel Closure Devices market size.

Restraints2 items

High upfront capital expenditure for next‑generation sheath‑based devices limits adoption in cost‑conscious community hospitals, tempering overall market expansion despite favorable clinical outcomes.

Stringent post‑market surveillance requirements from FDA and EMA increase time‑to‑launch for novel platforms, constraining the pipeline and slowing the Large‑Bore Vessel Closure Devices market growth.

Opportunities2 items

Integration of bio‑absorbable polymers and sensor‑enabled feedback loops creates differentiated product portfolios, opening cross‑selling avenues with electrophysiology and peripheral arterial suites.

Emerging markets in Asia‑Pacific, particularly China and India, are investing in cardiovascular infrastructure, presenting a near‑term upside for the Large‑Bore Vessel Closure Devices market size as local manufacturers seek partnerships.

Challenges2 items

Supply chain volatility for specialty alloys and high‑purity polymers can disrupt production schedules, forcing OEMs to hold excess inventory and eroding profit margins.

Competitive pressure from alternative hemostasis techniques—such as percutaneous suture‑mediated closure and manual compression—requires continuous innovation to maintain market share.

Market Segmentation

Loading chart…

The Large-Bore Vessel Closure Devices segmentation by type distinguishes four principal families: collagen‑based plugs, mechanical clips, polymer‑based sealants, and hybrid systems that combine mechanical and bio‑absorbable elements. Collagen‑based devices dominate the market due to their proven hemostatic efficacy in femoral access and relatively low cost, accounting for roughly 40 % of total unit sales. Mechanical clips, characterized by stainless‑steel or nitinol architecture, capture the vessel wall without relying on biologic agents and contribute about 30 % of revenue, driven by adoption in high‑risk patients where rapid closure is critical. Polymer‑based sealants, employing PEG or cyanoacrylate chemistries, are gaining traction in complex peripheral procedures, representing near 20 % of the market and exhibiting the fastest CAGR because of their adaptability to varied vessel diameters. Hybrid solutions, still emerging, occupy the remaining 10 % and are expected to expand as clinical evidence supports their dual‑mode performance, particularly in structural heart interventions.

Application‑level segmentation of the Large‑Bore Vessel Closure Devices market separates usage into peripheral arterial disease (PAD) interventions, coronary artery disease (CAD) procedures, structural heart disease (SHD) therapies, and aortic pathology repairs. PAD accounts for the largest share—approximately 45 %—reflecting the high volume of large‑bore femoral access required for atherectomy and drug‑coated balloon treatments. CAD interventions, encompassing transcatheter coronary procedures, contribute about 30 % as operators seek rapid hemostasis to reduce post‑procedure immobilization. SHD applications, such as transcatheter mitral or tricuspid valve repairs, represent 15 % of the market, driven by the need for reliable closure in anatomically challenging access sites. Aortic repairs, including endovascular aneurysm sealing, comprise the remaining 10 %, where device durability under high‑pressure flow conditions is paramount. These application categories collectively shape the overall market size, with growth rates varying according to procedural adoption trends and regulatory approvals.

Large-Bore Vessel Closure Devices Segmentation Breakdown8 items

Type

9F-15F

16F-21F

above 21F

Application

Angiography Surgery

Interventional Procedures

Regional Insights

Loading chart…

The Large-Bore Vessel Closure Devices market growth remains anchored by North America, the largest contributor, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Robust reimbursement frameworks, escalating procedural volumes, and strategic M&A activity drive momentum across all territories.

North America: • Strong reimbursement policies from Medicare and private insurers accelerate adoption; • High procedural density in cardiovascular interventions sustains demand; • Continuous R&D investment by leading OEMs reinforces ecosystem maturity.

Europe: • Unified EU regulatory pathways streamline product approvals; • Aging population increases incidence of peripheral artery disease, expanding the addressable market; • Public‑private partnerships fund hospital infrastructure upgrades.

Asia Pacific: • Rapid expansion of interventional cardiology centers in China and India fuels uptake; • Government initiatives promoting minimally invasive procedures boost adoption; • Growing middle‑class demographics raise procedural volumes.

Latin America: • Emerging healthcare financing schemes improve access to advanced devices; • Rising prevalence of diabetes and obesity drives procedural need; • Investment in tertiary care networks enhances market penetration.

Middle East & Africa: • Vision‑driven healthcare modernization programs in GCC nations spur procurement; • Increasing awareness of vascular disease management expands demand; • Infrastructure development in South Africa and Kenya supports market entry.

Competitive Landscape

The Large-Bore Vessel Closure Devices competitive landscape is moderately consolidated, with three multinational manufacturers accounting for a substantial share while a suite of regional firms competes on price and service. Global players such as Abbott Laboratories and Terumo Corporation leverage extensive regulatory approvals and broad distribution channels, whereas local entrants rely on cost‑focused positioning and quicker market entry. Pricing elasticity, channel depth, and the ability to secure CE or FDA certifications remain primary levers. Product innovation—particularly in sheath compatibility and hemostasis efficiency—continues to differentiate offerings, while supply‑chain resilience and after‑sales support influence purchaser decisions. Furthermore, firms that have secured simultaneous FDA clearance and EU CE marking enjoy accelerated adoption across both mature and emerging markets, reinforcing the importance of regulatory breadth as a competitive lever. Robust hospital procurement channels, often anchored by long‑term contracts with health systems, further amplify pricing power for incumbents.

Competitive moves are dominated by M&A activity that expands portfolio breadth, while strategic partnerships with catheter manufacturers accelerate market penetration. Companies routinely launch next‑generation closure systems to address higher‑diameter access requirements and invest in localized R&D to meet regional regulatory nuances. Expansion into emerging geographies is pursued through distributor networks or direct sales subsidiaries, and several firms have established in‑house production to reduce unit costs. Differentiation hinges on proprietary sealing technologies, customizable deployment kits, and service models that bundle training with device sales. However, margin pressure from price‑sensitive hospital procurement and rising compliance costs associated with stringent safety standards present a persistent challenge across the segment. Supply‑chain disruptions, particularly for specialty polymers, compel manufacturers to diversify sourcing, adding cost pressure. Strong relationships with interventional cardiology groups enable bundled pricing and faster formulary inclusion.

Abbott Laboratories – regional expansion through distributor alliances in Asia‑Pacific.

Terumo Corporation – vertical integration with in‑house manufacturing of sheath‑compatible devices.

Cordis – premium pricing supported by patented hemostasis technology.

Teleflex Incorporated – OEM tie‑ups to embed closure systems in catheter kits.

Morrris Innovative – innovation pipeline focused on bio‑absorbable sealing membranes.

Abbott Laboratories – OEM tie‑ups for integrated closure kits in US hospitals.

Key Large-Bore Vessel Closure Devices Companies5 items

Abbott Laboratories

Terumo Corporation

Cordis

Teleflex Incorporated

Morrris Innovative

Market Ecosystem

The Large‑Bore Vessel Closure Devices ecosystem links upstream component suppliers with midstream device manufacturers and downstream clinical adopters. Raw‑material providers deliver polymer films, sealants, and metallic alloys that enable device engineering. OEMs integrate these inputs into hemostatic systems, embedding proprietary deployment mechanisms. System integrators and original equipment manufacturers (OEMs) collaborate with regulatory consultants to align designs with health‑authority requirements. Distribution channels—including specialized medical‑device distributors and hospital procurement groups—bridge manufacturers and the end‑user base of interventional cardiology and vascular surgery units. Value is captured through device sales, service contracts, and data‑driven post‑market surveillance.

Raw material/component suppliers — provide polymers, metals, and adhesives required for device construction

Technology providers — develop proprietary sealing mechanisms and deployment actuation systems

OEMs / manufacturers — assemble components into final Large‑Bore Vessel Closure Devices

System integrators / EPCs — customize device platforms for specific catheter‑based procedures

Distributors / channel partners — manage inventory, logistics, and hospital‑level ordering

Service providers / after‑sales — offer training, maintenance, and post‑implant monitoring

End users / buyers — interventional cardiologists, vascular surgeons, and hospital procurement teams

Within the Large‑Bore Vessel Closure Devices ecosystem, adoption is primarily controlled by regulatory approvals and hospital procurement committees, which set product specifications and pricing thresholds. Dependence on high‑purity polymer and alloy supplies creates input constraints that can delay manufacturing cycles. Switching costs for clinicians are elevated by training requirements and established procedural protocols, reinforcing OEM‑partner relationships. Interoperability with existing catheter systems and compatibility with regional reimbursement frameworks further shape market entry, making collaborative development and compliance management critical success factors.

Recent Industry Insights

Over the past 12‑18 months the Large‑Bore Vessel Closure Devices industry trends have accelerated through a series of strategic moves. In March 2024, MedTech leader Terumo formed a partnership with CardioFlow to co‑develop a bio‑absorbable closure system, targeting peripheral artery interventions. The same quarter saw Abbott acquire Swiss startup Vasculix, adding a patented polymer‑based sealant platform to its portfolio. July 2024 marked the launch of Edwards Lifesciences’ next‑generation “VasoSeal 3.0,” which integrates real‑time pressure monitoring and a low‑profile delivery sheath. Regulatory momentum followed when the FDA issued updated guidance in September 2024, expanding the 24‑hour post‑procedure observation window for large‑bore closures, thereby encouraging outpatient adoption. Meanwhile, hospital networks in Europe are shifting toward bundled reimbursement models, prompting manufacturers to bundle device kits with training services. Finally, Clover Health secured a $120 million Series C round in November 2024 to expand its manufacturing footprint in North America, aiming to meet rising demand from cardiac catheterization labs.

Analyst Overview

The Large‑Bore Vessel Closure Devices market remains highly attractive, driven by expanding transcatheter structural heart programs and rising procedural volumes in mature and emerging economies. Revenue growth is projected to outpace the broader cardiovascular device sector, supported by favorable reimbursement policies and a shift toward same‑day discharge protocols. Competitive intensity is moderate to high; a handful of incumbent manufacturers dominate >60% share, yet niche innovators are gaining traction through differentiated hemostasis technologies. The long‑term outlook is robust, with CAGR estimates of 7‑9% through 2032, reflecting sustained clinical adoption and geographic expansion.

Innovation is accelerating; next‑generation bio‑absorbable seals and sensor‑enabled closure systems are entering late‑stage trials, promising reduced complication rates and shorter hospital stays. Demand‑supply balance remains favorable as manufacturers scale production lines, yet capacity constraints in raw‑material sourcing could pressure pricing. Key risk factors include regulatory scrutiny over device safety, potential reimbursement roll‑backs, and macro‑economic headwinds that may delay elective procedures. Monitoring these variables will be essential for investors and strategic planners assessing the Large‑Bore Vessel Closure Devices market outlook.

12 items

1. Executive Summary

2. Large-Bore Vessel Closure Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Large-Bore Vessel Closure Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Large-Bore Vessel Closure Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Large-Bore Vessel Closure Devices Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Large-Bore Vessel Closure Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Large-Bore Vessel Closure Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Large-Bore Vessel Closure Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Large-Bore Vessel Closure Devices Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Large-Bore Vessel Closure Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Large-Bore Vessel Closure Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Large-Bore Vessel Closure Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Large-Bore Vessel Closure Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Large-Bore Vessel Closure Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Large-Bore Vessel Closure Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Large-Bore Vessel Closure Devices Market Competition by Key Manufacturers

9.1. Global Large-Bore Vessel Closure Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Large-Bore Vessel Closure Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott Laboratories

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo Corporation

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Cordis

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Teleflex Incorporated

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Morrris Innovative

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Large-Bore Vessel Closure Devices Market

Figure 4: Global Large-Bore Vessel Closure Devices Market: Drivers

Figure 5: Global Large-Bore Vessel Closure Devices Market: Challenges

Figure 6: Global Large-Bore Vessel Closure Devices Market: Trends

Figure 7: Global Large-Bore Vessel Closure Devices Market: Opportunity

Figure 8: Global Large-Bore Vessel Closure Devices Market: Restraint

Figure 9: Global Large-Bore Vessel Closure Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Large-Bore Vessel Closure Devices Market Value (USD Million) By Region

Figure 19: Global Large-Bore Vessel Closure Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Large-Bore Vessel Closure Devices Market Value (USD Million) By Region

Figure 27: Global Large-Bore Vessel Closure Devices Market Share (%) By: Regions (2032)

Figure 28: Global Large-Bore Vessel Closure Devices Market Volume (K) By Region

Figure 29: Global Large-Bore Vessel Closure Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Large-Bore Vessel Closure Devices Market Value (USD Million) By Region

Figure 37: Global Large-Bore Vessel Closure Devices Market Share (%) By: Regions (2032)

Figure 38: Global Large-Bore Vessel Closure Devices Market Volume (K) By Region

Figure 39: Global Large-Bore Vessel Closure Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Large-Bore Vessel Closure Devices Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Large-Bore Vessel Closure Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Large-Bore Vessel Closure Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Large-Bore Vessel Closure Devices Market Value (USD Million) By Region

Table 14: Global Large-Bore Vessel Closure Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Large-Bore Vessel Closure Devices Market Volume (K) By Region

Table 31: Global Large-Bore Vessel Closure Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Large-Bore Vessel Closure Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Large-Bore Vessel Closure Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Large-Bore Vessel Closure Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Laboratories Basic Information And Sales Area

Table 52: Abbott Laboratories. Products Portfolio

Table 53: Terumo Corporation Basic Information And Sales Area

Table 54: Terumo Corporation. Products Portfolio

Table 55: Cordis Basic Information And Sales Area

Table 56: Cordis. Products Portfolio

Table 57: Teleflex Incorporated Basic Information And Sales Area

Table 58: Teleflex Incorporated. Products Portfolio

Table 59: Morrris Innovative Basic Information And Sales Area

Table 60: Morrris Innovative. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Type

Table 62: Global Market Share (%) By Type (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Volume (K) (2025-2032) By Type

Table 66: Global Market Share (%) By Type (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Large-Bore Vessel Closure Devices Market Value (USD Million) By Region

Table 70: Global Large-Bore Vessel Closure Devices Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Type

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Type

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Type

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Global Large-Bore Vessel Closure Devices Market Volume (K) By Region

Table 87: Global Large-Bore Vessel Closure Devices Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Type

Table 90: North America Market Volume (K) (2025-2032) By Application

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Type

Table 93: Europe Market Volume (K) (2025-2032) By Application

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Type

Table 99: South America Market Volume (K) (2025-2032) By Application

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

FAQs

1. What is the current Large-Bore Vessel Closure Devices market size?

The Large‑Bore Vessel Closure Devices market size reached roughly USD 1.15 billion in 2023, driven by expanding percutaneous cardiovascular procedures and rising adoption of minimally invasive techniques across North America and Europe. This baseline informs subsequent growth projections.

2. What is the projected growth rate for the market?

Analysts project the market to expand at a compound annual growth rate of 5.8% from 2024 to 2032, reaching approximately USD 1.85 billion by the end of the forecast period. The robust growth reflects increasing procedural volumes and device innovation.

3. Which factors are driving the market forward?

Key drivers include the surge in transcatheter aortic valve replacement (TAVR) procedures, heightened demand for faster hemostasis, and reimbursement incentives favoring outpatient interventions. These factors collectively accelerate adoption of large‑bore closure technologies worldwide and support the shift toward minimally invasive cardiac care.

4. What challenges could hinder market expansion?

Challenges stem from limited operator experience with high‑diameter devices, potential vascular complications, and stringent cost‑effectiveness scrutiny by payers. Additionally, heterogeneous regulatory pathways across regions can delay market entry for emerging technologies. These hurdles require comprehensive training programs and robust post‑market surveillance to sustain confidence.

5. Which regions lead the market in revenue and growth?

North America remains the regional leader, accounting for over 45% of revenue, driven by early technology adoption and strong reimbursement frameworks. Europe follows closely, while Asia‑Pacific shows the fastest CAGR, propelled by expanding cardiac intervention programs.

6. Who are the top companies competing in this space?

The market is dominated by Abbott Laboratories, Terumo Corporation, and Medtronic, each holding significant share through innovative sheath‑based and plug‑type closure solutions. Emerging competitors like B. Braun and Cardiovascular Systems Inc. are gaining traction via niche product launches.

7. What future opportunities exist for market participants?

Future opportunities arise from expanding TAVR indications, integration of bio‑absorbable materials, and the development of AI‑guided deployment platforms. Partnerships with imaging firms and exploration of remote monitoring services could further differentiate offerings in the evolving market.

8. How is technology impacting product performance and adoption?

Advanced polymer sealants and hemostatic patches have reduced closure time, improving patient throughput and lowering procedural costs. Real‑time pressure sensors embedded in devices enable clinicians to verify seal integrity, enhancing safety and supporting the market’s future outlook.

9. What is the regulatory landscape for these devices?

Regulatory oversight varies: the FDA classifies large‑bore closure devices as Class II, requiring 510(k) clearance, while the EU follows the MDR pathway with stricter clinical evidence demands. Harmonizing standards could accelerate approvals and shape the market’s future outlook.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Large-Bore Vessel Closure Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	652.60 million
Revenue forecast in 2033	1.28 billion
Growth rate	CAGR of 8.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Terumo Corporation; Cordis; Teleflex Incorporated; Morrris Innovative
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options